Assay Detail
Binding
CHEMBL5121196
Review assay metadata, readout intent, target linkage, and publication context from the same page.
Antagonist activity at ERalpha (unknown origin)
38
Total Activities
19
Compounds Tested
2
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Binding |
| Organism | Homo sapiens |
| Confidence | 9 — Direct single protein target |
| Curated By | Autocuration |
Publication
Human estrogen receptor α antagonists, part 2: Synthesis driven by rational design, in vitro antiproliferative, and in vivo anticancer evaluation of innovative coumarin-related antiestrogens as breast cancer suppressants.
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| IC50 | 19 | 8.50 | 9.72 |
| Ka | 19 | - | - |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL5199803 | — | — | 2 | 9.72 |
| CHEMBL5184399 | — | — | 2 | 9.59 |
| CHEMBL5178058 | — | — | 2 | 9.48 |
| CHEMBL5195371 | — | — | 2 | 9.41 |
| CHEMBL5191405 | — | — | 2 | 9.17 |
| CHEMBL5174813 | — | — | 2 | 9.15 |
| CHEMBL81 | RALOXIFENE | 4.0 | 2 | 9.13 |
| CHEMBL5187253 | — | — | 2 | 9.12 |
| CHEMBL5207726 | — | — | 2 | 9.12 |
| CHEMBL135 | ESTRADIOL | 4.0 | 2 | 9.05 |
| CHEMBL5203282 | — | — | 2 | 8.98 |
| CHEMBL5178110 | — | — | 2 | 8.95 |
| CHEMBL489 | AFIMOXIFENE | 3.0 | 2 | 8.95 |
| CHEMBL5181808 | — | — | 2 | 7.43 |
| CHEMBL5187730 | — | — | 2 | 7.41 |
| CHEMBL5198828 | — | — | 2 | 6.84 |
| CHEMBL5209099 | — | — | 2 | 6.79 |
| CHEMBL5194045 | — | — | 2 | 6.77 |
| CHEMBL5196340 | — | — | 2 | 6.43 |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL5199803 | — | IC50 | = | 0.19 | nM | 9.72 |
| CHEMBL5184399 | — | IC50 | = | 0.26 | nM | 9.59 |
| CHEMBL5178058 | — | IC50 | = | 0.33 | nM | 9.48 |
| CHEMBL5195371 | — | IC50 | = | 0.39 | nM | 9.41 |
| CHEMBL5191405 | — | IC50 | = | 0.67 | nM | 9.17 |
| CHEMBL5174813 | — | IC50 | = | 0.71 | nM | 9.15 |
| CHEMBL81 | RALOXIFENE | IC50 | = | 0.74 | nM | 9.13 |
| CHEMBL5187253 | — | IC50 | = | 0.76 | nM | 9.12 |
| CHEMBL5207726 | — | IC50 | = | 0.75 | nM | 9.12 |
| CHEMBL135 | ESTRADIOL | IC50 | = | 0.89 | nM | 9.05 |
| CHEMBL5203282 | — | IC50 | = | 1.05 | nM | 8.98 |
| CHEMBL5178110 | — | IC50 | = | 1.13 | nM | 8.95 |
| CHEMBL489 | AFIMOXIFENE | IC50 | = | 1.12 | nM | 8.95 |
| CHEMBL5181808 | — | IC50 | = | 37.0 | nM | 7.43 |
| CHEMBL5187730 | — | IC50 | = | 39.0 | nM | 7.41 |
| CHEMBL5198828 | — | IC50 | = | 143.93 | nM | 6.84 |
| CHEMBL5209099 | — | IC50 | = | 160.53 | nM | 6.79 |
| CHEMBL5194045 | — | IC50 | = | 168.41 | nM | 6.77 |
| CHEMBL5196340 | — | IC50 | = | 375.32 | nM | 6.43 |
| CHEMBL5178058 | — | Ka | = | 0.07 | nM | - |
| CHEMBL5209099 | — | Ka | = | 36.07 | nM | - |
| CHEMBL5184399 | — | Ka | = | 0.06 | nM | - |
| CHEMBL5198828 | — | Ka | = | 32.34 | nM | - |
| CHEMBL5187253 | — | Ka | = | 0.17 | nM | - |
| CHEMBL5196340 | — | Ka | = | 84.34 | nM | - |
| CHEMBL5199803 | — | Ka | = | 0.04 | nM | - |
| CHEMBL5181808 | — | Ka | = | 0.04 | nM | - |
| CHEMBL5187730 | — | Ka | = | 0.08 | nM | - |
| CHEMBL5195371 | — | Ka | = | 0.08 | nM | - |
| CHEMBL5174813 | — | Ka | = | 0.16 | nM | - |
| CHEMBL5207726 | — | Ka | = | 0.17 | nM | - |
| CHEMBL5203282 | — | Ka | = | 0.24 | nM | - |
| CHEMBL5178110 | — | Ka | = | 0.25 | nM | - |
| CHEMBL5191405 | — | Ka | = | 0.15 | nM | - |
| CHEMBL5194045 | — | Ka | = | 37.84 | nM | - |
| CHEMBL135 | ESTRADIOL | Ka | = | 0.2 | nM | - |
| CHEMBL489 | AFIMOXIFENE | Ka | = | 0.25 | nM | - |
| CHEMBL81 | RALOXIFENE | Ka | = | 0.17 | nM | - |